BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33538093)

  • 1. Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial.
    Kurch L; Mauz-Körholz C; Fosså A; Georgi TW; Kluge R; Bartelt JM; Kunze C; Wohlgemuth WA; Pelz T; Vordermark D; Plößl S; Hasenclever D; Sabri O; Landman-Parker J; Wallace WH; Karlen J; Fernández-Teijeiro A; Cepelova M; Klekawka T; Løndalen AM; Steiner D; Krombach G; Attarbaschi A; Hoffmann M; Ceppi F; Pears J; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Körholz D; Stoevesandt D
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28903. PubMed ID: 33538093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma].
    Kluge R; Körholz D
    Klin Padiatr; 2011 Nov; 223(6):315-9. PubMed ID: 22012607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group.
    Seelisch J; De Alarcon PA; Flerlage JE; Hoppe BS; Kaste SC; Kelly KM; Kurch L; Marks LJ; Mauz-Koerholz C; McCarten K; Metzger ML; Stroevesandt D; Voss SD; Punnett A
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28361. PubMed ID: 32672879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
    Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
    Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö; Baran Y; Oral A; Ceylan Y
    Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease.
    Furth C; Denecke T; Steffen I; Ruf J; Voelker T; Misch D; Vondran F; Plotkin M; Stöver B; Henze G; Lemke AJ; Amthauer H
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):501-12. PubMed ID: 16912590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
    Regacini R; Puchnick A; Luisi FAV; Lederman HM
    Pediatr Radiol; 2018 May; 48(5):638-647. PubMed ID: 29362839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients.
    Georgi TW; Stoevesandt D; Kurch L; Bartelt JM; Hasenclever D; Dittmann H; Ferda J; Francis P; Franzius C; Furth C; Gräfe D; Gussew A; Hüllner M; Menezes LJ; Mustafa M; Stegger L; Umutlu L; Zöphel K; Zucchetta P; Körholz D; Sabri O; Mauz-Körholz C; Kluge R
    J Nucl Med; 2023 Jan; 64(1):96-101. PubMed ID: 35835583
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
    Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E
    Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL).
    Hagleitner MM; Metzger ML; Flerlage JE; Kelly KM; Voss SD; Kluge R; Kurch L; Cho S; Mauz-Koerholz C; Beishuizen A
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28365. PubMed ID: 32491274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Body Diffusion-Weighted MRI Compared to
    Shapira-Zaltsberg G; Wilson N; Trejo Perez E; Abbott L; Dinning S; Kapoor C; Davila J; Smith B; Miller E
    Can Assoc Radiol J; 2020 May; 71(2):217-225. PubMed ID: 32062992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imaging features of Waldeyer's ring in non-Hodgkin's lymphoma and its clinical significance].
    Huang SF; Zhang LF; He X; Shen WR; Gu ZY
    Ai Zheng; 2004 Nov; 23(11):1325-8. PubMed ID: 15522183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
    Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK
    Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.
    Grellier JF; Vercellino L; Leblanc T; Merlet P; Thieblemont C; Weinmann P; Toubert ME; Berenger N; Brière J; Brice P
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2023-30. PubMed ID: 24965842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
    Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
    Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body [
    Kurch L; Kluge R; Sabri O; Fischer L; Wendt S; Graf Einsiedel H; Starke S; Kühl JS; Christiansen H; Hirsch FW; Sorge I; Roth C
    EJNMMI Res; 2021 Jul; 11(1):62. PubMed ID: 34216300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.